• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Approaches for improving the stability of ketorolac in powder blends.

作者信息

Brandl M, Magill A, Rudraraju V, Gordon M S

机构信息

Pharmaceutical Research, Syntex Research, Palo Alto, CA 94304, USA.

出版信息

J Pharm Sci. 1995 Oct;84(10):1151-3. doi: 10.1002/jps.2600841003.

DOI:10.1002/jps.2600841003
PMID:8801326
Abstract

Methods for improving the stability of ketorolac powder blends under elevated humidity and temperature conditions were investigated. The approaches that were examined for potentially increasing the stability of ketorolac were varying the ketorolac salt form, altering the excipient ratios, and adding antioxidants or pH modifiers to the formulation. The ketorolac powder blends were stored for 3 months at 75% relative humidity (RH) and 40, 50, and 60 degrees C. The results showed that the salt form of ketorolac had a large impact on stability after 3 months of storage at 50 degrees C/75% RH. The calcium salt powder blend and the free acid powder blend exhibited only 0.2% and 0.5% drug loss, respectively, whereas the tromethamine salt powder blend showed a 10.2% drug loss. Varying the ratios of lactose, microcrystalline cellulose, and croscarmellose sodium in the powder blends of ketorolac tromethamine showed that croscarmellose sodium and microcrystalline cellulose destabilized ketorolac. Addition of propyl gallate (1% w:w) to ketorolac tromethamine powder blends increased the stability of the ketorolac significantly. Addition of pH modifiers caused a modest improvement in the stability of ketorolac.

摘要

相似文献

1
Approaches for improving the stability of ketorolac in powder blends.
J Pharm Sci. 1995 Oct;84(10):1151-3. doi: 10.1002/jps.2600841003.
2
Racemization of ketorolac in aqueous solution.
J Pharm Sci. 1995 Sep;84(9):1045-8. doi: 10.1002/jps.2600840903.
3
Microencapsulation of ketorolac tromethamine by means of a coacervation-phase separation technique induced by the addition of non-solvent.
J Microencapsul. 1998 Jan-Feb;15(1):45-53. doi: 10.3109/02652049809006834.
4
Repackaging ketorolac injection.
Am J Health Syst Pharm. 1998 Feb 15;55(4):388-91. doi: 10.1093/ajhp/55.4.388.
5
Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.湿度引起的含有不同载体的干粉气雾剂制剂空气动力学性质的变化。
Int J Pharm. 2007 Mar 21;333(1-2):45-55. doi: 10.1016/j.ijpharm.2006.09.048. Epub 2006 Oct 1.
6
[Ketorolac tromethamine--with special reference to postoperative pain therapy].[酮咯酸氨丁三醇——特别涉及术后疼痛治疗]
Ugeskr Laeger. 1994 Feb 21;156(8):1160-3.
7
Incompatibility of ketorolac tromethamine with selected postoperative drugs.酮咯酸氨丁三醇与部分术后用药的配伍禁忌
Am J Hosp Pharm. 1992 Dec;49(12):2960-2.
8
Transdermal delivery of ketorolac tromethamine: permeation enhancement, device design, and pharmacokinetics in healthy humans.酮咯酸氨丁三醇的经皮给药:在健康人体中的渗透增强、装置设计及药代动力学
J Pharm Sci. 1995 Oct;84(10):1190-6. doi: 10.1002/jps.2600841010.
9
Assessment of powder blend uniformity: Comparison of real-time NIR blend monitoring with stratified sampling in combination with HPLC and at-line NIR Chemical Imaging.粉末混合均匀性评估:实时近红外混合监测与分层抽样结合高效液相色谱法及在线近红外化学成像的比较
Eur J Pharm Biopharm. 2015 Nov;97(Pt A):78-89. doi: 10.1016/j.ejpb.2015.10.002. Epub 2015 Oct 9.
10
Compatibility of ketorolac tromethamine injection with common infusion fluids and administration sets.酮咯酸氨丁三醇注射液与常用输液及输液器的相容性
Am J Hosp Pharm. 1990 May;47(5):1097-100.

引用本文的文献

1
Microenvironmental pH Modification in Buccal/Sublingual Dosage Forms for Systemic Drug Delivery.用于全身给药的口腔/舌下剂型的微环境pH调节
Pharmaceutics. 2023 Feb 14;15(2):637. doi: 10.3390/pharmaceutics15020637.
2
MUPS Tableting-Comparison between Crospovidone and Microcrystalline Cellulose Core Pellets.微晶纤维素核丸剂与交联聚维酮的胃溶型药用辅料片压制比较
Pharmaceutics. 2022 Dec 15;14(12):2812. doi: 10.3390/pharmaceutics14122812.
3
Review on Starter Pellets: Inert and Functional Cores.关于起始颗粒的综述:惰性核心与功能性核心
Pharmaceutics. 2022 Jun 18;14(6):1299. doi: 10.3390/pharmaceutics14061299.
4
Modulation of the Release of a Non-Interacting Low Solubility Drug from Chitosan Pellets Using Different Pellet Size, Composition and Numerical Optimization.使用不同的微丸尺寸、组成和数值优化方法调节壳聚糖微丸中一种非相互作用的低溶解度药物的释放
Pharmaceutics. 2019 Apr 10;11(4):175. doi: 10.3390/pharmaceutics11040175.
5
A Quality by Experimental Design Approach to Assess the Effect of Formulation and Process Variables on the Extrusion and Spheronization of Drug-Loaded Pellets Containing Polyplasdone® XL-10.一种采用实验设计方法评估制剂和工艺变量对含聚维酮XL - 10的载药微丸挤出和滚圆效果的质量研究
AAPS PharmSciTech. 2016 Apr;17(2):368-79. doi: 10.1208/s12249-015-0345-6. Epub 2015 Jul 14.
6
Use of fine particle ethylcellulose as the diluent in the production of pellets by extrusion-spheronization.使用细颗粒乙基纤维素作为挤出滚圆法生产丸剂的稀释剂。
Saudi Pharm J. 2014 Sep;22(4):360-72. doi: 10.1016/j.jsps.2013.11.001. Epub 2013 Nov 16.
7
Effect of carbonate salts on the kinetics of acid-catalyzed dimerization of adefovir dipivoxil.碳酸盐对阿德福韦酯酸催化二聚反应动力学的影响。
Pharm Res. 2000 Sep;17(9):1098-103. doi: 10.1023/a:1026457729708.